7/16/2008

Shire PLC has filed patent-infringement suits against Nostrum Pharmaceuticals and Apotex for seeking approval to market generic copies of Carbatrol, its anti-seizure drug. The patents involved in the dispute are set to expire in 2011 and 2016.

Full Story:
FDAnews

Related Summaries